top of page
Welcome to the Galvan Lab
Mapping the molecular pathways that link aging to Alzheimer's disease
We seek to understand the molecular processes of aging that drive Alzheimer's disease (AD), and to define the therapeutic potential of drug candidate molecules in treating AD.
We use genetic manipulations in rodents, in vivo optical and MRI- and PET-based brain imaging, laser Doppler-based cerebral blood flow measures, primary cell culture systems and a range of biochemical, cellular and molecular biology approaches, together with single-cell -omic and behavioral tools.
Our ultimate goal is to advance our understanding of age-related neurodegenerations, including AD, and to identify potential interventions to treat them or delay their progression.
IMG_3741
Stacy at ICAD 2023
South Texas AD Conference Awards
IMG_3741
bottom of page